What is Nurix Therapeutics, Inc.'s net change in cash?

Nurix Therapeutics, Inc. (NRIX) reported net change in cash of -$175.77M in Q4 2025.

How has Nurix Therapeutics, Inc.'s net change in cash changed year-over-year?

Nurix Therapeutics, Inc.'s net change in cash decreased by 415.7% year-over-year, from -$34.08M to -$175.77M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Nurix Therapeutics, Inc. NRIX Net Change in Cash

Net Change in Cash at other companies

Kymera TherapeuticsKYMR

-$212.91M-603%

Monte Rosa Therapeutics, Inc.GLUE

$29.97M+121%

Stoke Therapeutics, Inc.STOK

$74.44M-49.3%

Viridian Therapeutics, Inc.VRDN

-$36.04M-317%

Nuvation BioNUVB

-$38.7M-416%

Ultragenyx PharmaceuticalRARE

-$247M-449%

Other financials

Income statement

See full

Revenue$6.3M-66.1%

Operating income-$92.5M-47.1%

Net income-$87.2M-54.7%

EPS (diluted)-$0.79-17.9%

Balance sheet

See full

Cash & equivalents$72.2M-6.1%

Total debt$58.7M+120%

Total equity$480.9M0.0%

Total assets$636.1M+3.4%

Cash flow

See full

Operating cash flow-$71.9M-17.7%

CapEx$1.0M-70.0%

Free cash flow-$73.0M-13.0%

Valuation

See full

Market cap$1.95B+40.1%

Enterprise value$1.94B+45.1%

P/S27.2×+2.5×

Profitability

See full

Operating margin-439.3%+35.3pp

Net margin-411.4%+52.7pp

FCF margin-378.7%+24.1pp

Returns & leverage

See full

Return on equity-61.4%-2.5pp

Debt / equity0.1×+0.1×

Current ratio6×-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s net change in cash?: Nurix Therapeutics, Inc. (NRIX) reported net change in cash of -$175.77M in Q4 2025.
How has Nurix Therapeutics, Inc.'s net change in cash changed year-over-year?: Nurix Therapeutics, Inc.'s net change in cash decreased by 415.7% year-over-year, from -$34.08M to -$175.77M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.